酒精使用障碍的当前治疗方法
Tommaso Dionisi1, Giovanna Di Sario1, Lorenzo De Mori2
1Unit of Internal Medicine, Department of Medical and Surgical Sciences, IRCCS "A. Gemelli" University Polyclinic Foundation, Rome, Italy.
International review of neurobiology
|March 30, 2024
概括
酒精使用障碍 (AUD) 的新疗法针对神经生物学和心理学. 个性化医学,利用遗传因素,提高了酒精依赖的治疗效果.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 酒精使用障碍 (AUD) 涉及复杂的神经生物学,心理和间接因素.
- 目前的治疗方法操纵神经递质系统,如GABA,谷氨酸,多巴胺,血清素和乙胆.
- 创新的方法包括GABA再吸收抑制和全调节.
研究的目的:
- 审查酒精使用障碍 (AUD) 的新兴治疗方法.
- 突出神经生物学和心理学策略的整合.
- 强调个性化医学在优化AUD治疗中的作用.
主要方法:
- 探索神经递质系统的操纵 (GABA,谷氨酸,多巴胺,血清素,乙胆).
- 研究新的机制,如GABA再吸收抑制和全调节.
- 在AUD治疗的个性化医学中应用药物基因组学原理.
主要成果:
- 谷氨酸在慢性酒精消费中的作用正在审查中,NMDA受体对抗剂显示出有前途.
- 考虑到遗传和表观遗传因素的个性化医学对于优化治疗反应至关重要.
- 心理治疗是解决成的认知行为方面不可或缺的组成部分.
结论:
- 由于AUD的全球流行率很高,因此持续需要改进AUD治疗方法.
- 研究正在朝着更复杂的,基于类型的酒精依赖治疗方法前进.
- 未来的战略有望提高临床相关性和有效性,以应对酒精依赖.
更多相关视频
相关概念视频
CNS Depressants: Alcohol and Nicotine
205
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
205
Substance Use Disorders Affecting Sleep
166
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
166
Alzheimer's Disease: Treatment
184
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
184
Binge Eating Disorders
63
Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
63
Depressants
116
Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
116
Drug Therapy
43
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
43


